Guidelines - A missed opportunity

Atherosclerosis

Volumn 143, Issue SUPPL. 1, 1999, Pages

  Wood, David ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Coronary heart disease Prevention; EUROASPIRE; Recommendations; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL PRACTICE; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE CONTROL; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; MASS SCREENING; OBESITY; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

CARDIOLOGY; CORONARY DISEASE; EUROPE; HUMANS; PRACTICE GUIDELINES; PREVENTIVE MEDICINE; SOCIETIES, MEDICAL;

EID: 0032977858     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00101-X     Document Type: Conference Paper

References (18)

1. Task Force, Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J. 15:1994;1300-1331.
2. Task Force, Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Atherosclerosis. 110:1994;121-161.
3. Task Force, Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Int Soc Hypertens News. 1:1995;6-12.
4. Bowker TJ, Clayton TC, Ingham Jet al. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). Heart. 75(4):1996;334-342.
5. EUROASPIRE Study Group EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J. 18:1997;1569-1582.
6. Shepherd J, Alcalde V, Befort P-A et al. International comparison of awareness and attitudes towards coronary risk factor reduction: the HELP study. J Cardiovasc Risk 1997;4:373-384.2.
7. Daly LE, Mulcahy R, Graham IM, Hickey N Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction. Br Med J (Clin Res Ed). 287(6388):1983;324-326.
8. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure The sixth report of the on Detection, Evaluation and Treatment of High Blood Pressure (JNC-VI). Arch Int Med. 157(21):1997;2413-2446.
9. Task Force, Wood D, de Backer G, Faergeman O, Graham I, Mancia G, Pyorala K Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J. 19:1998;1434-1503.
10. Task Force, Wood D, de Backer G, Faergeman O, Graham I, Mancia G, Pyorala K Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis. 140(2):1998;199-270.
11. Task Force, Wood D, de Backer G, Faergeman O, Graham I, Mancia G, Pyorala K Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens. 16(10):1998;1407-1414.
12. National Cholesterol Education Program (NCEP) Expert Panel Summary of the second report of the NCEP expert panel on detection, evaluation and treatment of high blood cholesterol. J Am Med Assoc. 209:1993;3015-3023.
13. Scandinavian Simvastatin Survival Study Group Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 344:1994;1383-1389.
14. Shekelle RB, Shryock AM, Paul Oet al. Diet, serum cholesterol and death from coronary heart disease: the Western Electric Study. N Engl J Med. 304:1981;65-70.
15. Robertson TL, Kato H, Gordon Tet al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Am J Epidemiol. 97:1973;372-385.
16. Burr ML, Fehily AM, Gilbert JFet al. Effects of changes in fat, fish, and fibre intakes on death and myocardial re-infarction: diet and re-infarction trial (DART). Lancet. 2(8666):1989;757-761.
17. de Lorgeril M, Renaud S, Mamelle Net al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 343(8911):1994;1454-1459.
18. Singh RB, Rastogi SS, Verma Ret al. Randomized controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. Br Med J. 304(6833):1992;1015-1019.